Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line

Breast Cancer Research and Treatment

Volumn 55, Issue 3, 1999, Pages 231-242

  Parisot, John P ^a   Leeding, Kerri S ^b   Hu, Xiu F ^a   DeLuise, Mario ^c   Zalcberg, John R ^a   Bach, Leon A ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Breast cancer; ICI 182,780; IGFBPs; Tamoxifen resistance

Indexed keywords

ESTROGEN; FULVESTRANT; SOMATOMEDIN BINDING PROTEIN; TAMOXIFEN;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CROSS LINKING; CULTURE MEDIUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; IODINE RADIOISOTOPES; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0032836115     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006274712664     Document Type: Article

References (46)

1. Hu XF, Veroni M, DeLuise M, Wakeling A, Sutherland R, Watts CK, Zalcberg JR: Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780. Int J Cancer 55: 873-876, 1993
2. Vignon F, Bouton MM, Rochefort H: Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146: 1502-1508, 1987
3. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynek R, Dickson KB: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417-428, 1987
4. Winston R, Kao P, Kiang D: Regulation of insulin-like growth factors by antiestrogen. Breast Cancer Res Treat 31: 107-115, 1994
5. Stewart AJ, Johnson MD, May FE, Westley BR: Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimutated proliferation of human breast cancer cells. J Biol Chem 265: 21172-82117, 1990
6. Thorsen T, Lahooti H, Rasmussen M, Aakvaag A: Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I. J Steroid Biochem Mol Biol 41: 537-540, 1992
7. Steele-Perkins G, Turner J, Edman JC, Hari J, Pierce SB, Stover C, Rutter WJ, Roth RA: Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem 263: 11486-11492, 1988
8. Nissley P, Lopaczynski W: Insulin-like growth factor receptors. Growth Factors 5: 29-43, 1991
9. Bach LA, Rechler MM: Insulin-like growth factor binding proteins. Diabetes Rev 5: 38-61, 1995
10. Clemmons DR, Camacho-Hubner C, Coranado E, Osborne CK: Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 127: 2679-2686, 1990
11. Jones JI, Clemmons DR: Insulin-like growth factor and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995
12. Collett-Solberg PE, Cohen P: The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 25: 591-614, 1996
13. Elgin R, Busby WH Jr, Clemmons D: An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84: 3254-3258, 1987
14. De Mellow JS, Baxter RC: Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156: 199-204, 1988
15. Jones JI, Gockerman A, Bushy WH Jr, Camacho-Hubner C, Clemmons DR: Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121: 679-687, 1993
16. Conover C: Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130: 3191-3199, 1992
17. Andress D, Birnbaum R: Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267: 22467-22472, 1992
18. Mohan S, Nakao Y, Honda Y, Landale H, Leser U, Dony C, Lang K, Baylink D: Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270: 20424-20431, 1995
19. Freiss C, Rochefort H, Vignon F: Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity. Biochem Biophys Res Commun 173: 919-926, 1990
20. Huynh H, Nickerson T, Pollak MN, Yang XE: Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780. Clin Cancer Res 2: 2037-2042, 1996
21. Pratt SE, Pollak MN: Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53: 5193-5198, 1993
22. Huynh H, Yang XE, Pollak MN: Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271: 1016-1021, 1996
23. Huynh H, Yang XE, Pollak MN: A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth Differ 7: 1501-1506, 1996
24. Musgrove FA, Sutherland RL: Acute effects of growth factors on T-47D breast cancer cell cycle progression. Eur J Cancer 29A: 2273-2279, 1993
25. Darbre PD, Yates J, Curtis S, King RJ: Effect of estradiol on human breast cancer cells in culture. Cancer Res 43: 349-354, 1983
26. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50: 48-53, 1990
27. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, Rosenfeld RG: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28: 619-637, 1996
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-276, 1951
29. Bach LA, Leeding KS, Leng SL: Regulation of IGF-binding protein-6 by dexamethasone and ICFs in PC 12 rat phacochromocytoma cells. J Endocrinol 155: 225-232, 1997
30. Parisot JP, Hu XF, DeLuise M, Zalcberg JR: Altered expression of the IGF-I receptor in a tamoxifen-resistant human breast cancer cell line. Br J Cancer 79: 693-700, 1999
31. Olney RC, Tsuchiya K, Wilson DM, Mohtai M, Maloney WJ, Schurman DJ, Smith RL: Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-1) and IGF-binding protein-3 (TGFBP-3) and -5, but not IGFBP-2 or IGFBP-4. J Clin Endocrinol Metabol 81: 1096-1103, 1996
32. Voutilainen R, Franks S, Mason HD, Martikainen H: Expression of insulin-like growth factor (IGH), IGF-binding protein, and IGF receptor messenger ribonucleic acids in normal and polycystic ovaries. J Clin Endocrinol Metabol 81: 1003-1008, 1996
33. Futscher B, Blake L, Gerlach J, Grogan T, Dalton W: Quantitative polymerase chain reaction analysis of mdrl mRNA in multiple myeloma cell lines and clinical specimens. Anal Biochem 213: 414-421, 1993
34. Wakeling AE, Dukes M, Bowler J: A potent specific pure anti-estrogen with clinical potential. Cancer Res 51: 3867-3873, 1991
35. Fawell SE, White R, Hoare S, Sydenham M, Page M, Parker MG: Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164, 384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci USA 87: 6883-6887, 1990
36. Dauvois S, Danielian PS, While R, Parker MG: Antiestrogen ICI 164, 384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89: 4037-4041, 1992
37. Parisot JP, Hu XE, Sutherland RL, Wakeling A, Zalcberg JR, DeLuise M: The pure antiestrogen ICI 182, 780 binds to a high-affinity site distinct from the estrogen receptor. Int Cancer 62: 480-484, 1995
38. Oh Y, Muller HL, Pham H, Rosenfeld RC: Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268, 26045-26048, 1993
39. Karas M, Danilenko M, Fishman D, LeRoith D, Levy J, Sharoni Y: Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells. J Biol Chem 272: 16514-16520, 1997
40. Shimasaki S, Shimonaka M, Zhang HP, Ling N: Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266: 10646-10653, 1991
41. McGuire SE, Hilsenbeck SC, Figueroa JA, Jackson JG, Yee D: Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues. Cancer Lett 77: 25-32, 1994
42. Grimes RW, Manni A, Hammond JM: Postsynthetic regulation of insulin-like growth factor-binding protein-3 by MCF-7 human breast cancer cells in culture, Breast Cancer Res Treat 39: 187-196, 1996
43. Adamo ML, Shao ZM, Lanau F, Chen JC, Clemmons DR, Roberts Jr CT, LeRoith D, Fontana JA: Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 131: 1858-1866, 1992
44. Rozen F, Yang XF, Huynh H, Pollak M: Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation. J NatI Cancer Inst 89: 652-656, 1997
45. Hwa V, Oh Y, Rosenfeld R: Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-beta and retinoic acid in the human prostate adenocarcinoma cell line PC-3. Endocrine 6: 235-242, 1997
46. Tonner E, Barber M, Travers M, Logan A, Flint D: Hormonal control of insulinlike growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 138: 5101-5107, 1997